METASTATIC ALVEOLAR SOFT PART SARCOMA
Clinical trials for METASTATIC ALVEOLAR SOFT PART SARCOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ALVEOLAR SOFT PART SARCOMA trials appear
Sign up with your email to follow new studies for METASTATIC ALVEOLAR SOFT PART SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo targets rare sarcoma in new trial
Disease control Recruiting nowThis study tests whether combining two drugs—atezolizumab (an immunotherapy) and selinexor (a growth blocker)—can shrink tumors in people with a rare cancer called alveolar soft part sarcoma that has spread or cannot be removed by surgery. About 27 adults with this cancer will re…
Matched conditions: METASTATIC ALVEOLAR SOFT PART SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Could less be more? new study tests lower cancer drug doses to cut side effects
Disease control Recruiting nowThis study tests whether giving a lower, less frequent dose of the cancer drug atezolizumab can still control tumors while causing fewer side effects. About 30 adults with advanced lung, liver, skin, or sarcoma cancers will receive the drug alone or with other treatments. Researc…
Matched conditions: METASTATIC ALVEOLAR SOFT PART SARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:13 UTC